» Articles » PMID: 33995352

Bridging Therapy for Acute Stroke As the Initial Manifestation of Takayasu Arteritis: A Case Report and Review of Literature

Overview
Journal Front Immunol
Date 2021 May 17
PMID 33995352
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Takayasu arteritis (TA) is a chronic inflammatory disease involving the aorta and its principal branches. Acute ischaemic stroke (AIS) as the initial manifestation of TA is uncommon. There is little evidence on the efficacy of bridging therapy for AIS induced by TA. A 23-year-old Chinese woman with a suspected stroke presented to our hospital with sudden onset of right-sided weakness, right facial palsy, and aphasia that occurred 1 hour ago. After physical and ancillary examinations, recombinant tissue plasminogen activator was administered to the patient, which led to partial recovery. Her neurological function deteriorated with a large salvageable ischaemic penumbra on computed tomography perfusion. Cerebrovascular angiography showed multiple stenoses in the brachiocephalic trunk, the beginning of the right common carotid artery (CCA), and the bilateral subclavian arteries, as well as occlusion of the left CCA and its branches. Mechanical thrombectomy of the left middle cerebral artery was performed immediately. Percutaneous transluminal balloon angioplasty of the left CCA followed by stent implantation of the proximal left CCA was then performed. A diagnosis of TA was made based on the findings. The patient's neurological deficit fully recovered with immunosuppressants at the 3 month-follow-up. We report a rare case of a patient with TA initially presenting with AIS treated with bridging therapy with full recovery of neurological function. Bridging therapy should be taken into consideration for AIS in patients with TA. Further study is needed in this regard.

Citing Articles

Multiple sclerosis in a patient with Takayasu's Arteritis: A case report.

Emam M, Abiyarghamsari M, Kazempour M, Haghighi-Morad M, Farsad F Caspian J Intern Med. 2024; 15(4):729-734.

PMID: 39359445 PMC: 11444114. DOI: 10.22088/cjim.15.4.729.


Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study.

Huo J, Wang B, Yu L, Gao D, Cheng R, Wang J Front Cardiovasc Med. 2022; 9:948124.

PMID: 35990973 PMC: 9385106. DOI: 10.3389/fcvm.2022.948124.


An Unusual Case of Stroke as the Initial Manifestation of Early Takayasu Arteritis with Normal Erythrocyte Sedimentation Rate (ESR): Diagnosis and Treatment.

Chiew Y, Seet Y Am J Case Rep. 2022; 23:e936321.

PMID: 35585775 PMC: 9128458. DOI: 10.12659/AJCR.936321.

References
1.
Perera A, Youngstein T, Gibbs R, Jackson J, Wolfe J, Mason J . Optimizing the outcome of vascular intervention for Takayasu arteritis. Br J Surg. 2013; 101(2):43-50. DOI: 10.1002/bjs.9372. View

2.
Kumar V, Dutt S, Bhat R . Takayasu's arteritis--stroke as an initial presentation. J Assoc Physicians India. 2015; 62(7):623-7. View

3.
Pereira V, de Freitas C, Luvizutto G, Sobreira M, Peixoto D, Magalhaes I . Stroke as the First Clinical Manifestation of Takayasu's Arteritis. Case Rep Neurol. 2015; 6(3):271-4. PMC: 4280462. DOI: 10.1159/000369783. View

4.
Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P . Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012; 125(6):813-9. DOI: 10.1161/CIRCULATIONAHA.111.058032. View

5.
Hotchi M . Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992; 7:11-7. DOI: 10.1007/BF01744538. View